We are live on ! Find out more
CI

Capital International Portfolio holdings

AUM $2.7B
1-Year Est. Return 31.08%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$2.45B
AUM Growth
+$131M
Cap. Flow
+$41.5M
Cap. Flow %
1.69%
Top 10 Hldgs %
35.95%
Holding
152
New
11
Increased
94
Reduced
39
Closed
7

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$13.3M
2
BSX icon
Boston Scientific
BSX
+$8.68M
3
NVDA icon
NVIDIA
NVDA
+$7.53M
4
C icon
Citigroup
C
+$7.39M
5
CTVA icon
Corteva
CTVA
+$7.3M

Top Sells

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$17.1M
2
ANET icon
Arista Networks
ANET
+$6.27M
3
AVGO icon
Broadcom
AVGO
+$6.08M
4
PM icon
Philip Morris
PM
+$5.67M
5
EFX icon
Equifax
EFX
+$5.62M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 18.13%
3 Healthcare 13.77%
4 Financials 12.82%
5 Communication Services 12.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLUT icon
126
Flutter Entertainment
FLUT
$15.9B
$2.96M 0.12%
11,445
+3,086
+37% +$779K
KO icon
127
Coca-Cola
KO
$374B
$2.75M 0.11%
+44,161
New +$2.88M
MU icon
128
Micron Technology
MU
$1.02T
$2.71M 0.11%
32,206
+303
+0.9% +$30.8K
ASND icon
129
Ascendis Pharma A/S
ASND
$16.5B
$2.64M 0.11%
+19,153
New +$2.52M
VALE icon
130
Vale
VALE
$63.7B
$2.47M 0.1%
278,653
-51,937
-16% -$529K
NVO
131
Novo Nordisk
NVO
$200B
$2.45M 0.1%
28,528
+3,856
+16% +$417K
SRPT icon
132
Sarepta Therapeutics
SRPT
$1.77B
$2.24M 0.09%
18,430
+4,357
+31% +$534K
BIRK icon
133
Birkenstock
BIRK
$6.86B
$2.22M 0.09%
39,175
-7
-0% -$355
ACN icon
134
Accenture
ACN
$101B
$2.19M 0.09%
6,235
+329
+6% +$118K
TTWO icon
135
Take-Two Interactive
TTWO
$43.1B
$2.18M 0.09%
11,840
+302
+3% +$52.4K
WDAY icon
136
Workday
WDAY
$40.9B
$2.17M 0.09%
8,428
-142
-2% -$36.3K
GGB icon
137
Gerdau
GGB
$9.97B
$1.69M 0.07%
586,778
-722,400
-55% -$2.38M
EQIX icon
138
Equinix
EQIX
$103B
$1.64M 0.07%
1,737
+14
+0.8% +$12.9K
SPOT icon
139
Spotify
SPOT
$97.6B
$1.43M 0.06%
+3,205
New +$1.37M
DBD icon
140
Diebold Nixdorf
DBD
$2.6B
$1.43M 0.06%
33,171
MSTR icon
141
Strategy Inc
MSTR
$37.3B
$1.4M 0.06%
+4,840
New +$1.46M
VLTO icon
142
Veralto
VLTO
$23.7B
$1.2M 0.05%
11,802
+4,166
+55% +$444K
TRU icon
143
TransUnion
TRU
$15.2B
$993K 0.04%
+10,706
New +$1.08M
SOBO
144
South Bow Corp
SOBO
$7.38B
$952K 0.04%
+40,336
New +$988K
KKR icon
145
KKR & Co
KKR
$94.1B
$397K 0.02%
+2,682
New +$393K
AZN icon
146
AstraZeneca
AZN
$249B
-19,620
Closed -$3.06M
CP icon
147
Canadian Pacific Kansas City
CP
$79.8B
-200,379
Closed -$17.1M
EW icon
148
Edwards Lifesciences
EW
$51B
-50,926
Closed -$3.36M
GTLS
149
DELISTED
Chart Industries
GTLS
-20,146
Closed -$2.5M
NICE icon
150
Nice
NICE
$5.7B
-1,173
Closed -$204K

Similar funds

Capital International's Q4 2024 Portfolio in Review

As of Q4 2024, Capital International held 152 positions worth $2.45B, up 5.7% from $2.32B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Capital International's Q4 2024 filing shows 11 new, 94 increased, 39 reduced and 7 closed positions. Its largest new stake was Illumina: 45,217 shares worth $6.04M. The largest sale was Canadian Pacific Kansas City, an estimated $17.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Capital International's largest Q4 2024 buy was Illumina: 45,217 shares worth $6.04M.
  • Capital International added most to Amazon in Q4 2024, an estimated $13.3M increase.
  • Capital International's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $6.27M.
  • Capital International fully exited Canadian Pacific Kansas City in Q4 2024, selling an estimated $17.1M.
  • Capital International's ten largest holdings make up 36% of its $2.45B portfolio in Q4 2024.
  • Capital International opened 11 new positions and closed 7 in Q4 2024.
  • Capital International's portfolio value rose 5.7% quarter-over-quarter to $2.45B.

Based on Capital International's 13F filing for Q4 2024, filed 13 Feb 2025.